Skip to main content

Table 2 GM/KM phenotypes in relation to IgG subclass-specific antibodies to PvAMA-1 in subjects exposed to malaria

From: Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1

Phenotypes

(Number of subjects)

Antibody levels (Reactivity Index) (Median, Interquartile range)

 

IgG1

IgG2

IgG3

IgG4

GM 1,2,17 21 (10)

b0.15(0.10-0.48)

0.02(0.01-0.62)

0.57(0.18-1.04)

0.06(0.01-0.64)

GM 1,17 5,13,14,21 (21)

c0.28(0.05-0.58)

0.4(0.05-1.21)

0.47(0.24-1.05)

0.37(0.05-0.75)

GM 1,2,3,17 23 5,13,14,21 (14)

1.09(0.54-3.70)

0.42(0.16-0.88)

0.45(0.26-0.73)

0.23(0.03-0.38)

GM 1,3,17 23 5,13,14,21 (33)

d2.02(0.61-3.67)

0.50(0.16-1.23)

0.66(0.31-1.72)

0.58(0.13-0.93)

GM 1,3,17 23 5,6,13,14 (10)

1.68(0.22-3.83)

0.01(0.01-0.30)

0.31(0.01-1.10)

0.60(0.01-0.91)

GM 1,3,17 5,13,14,21 (20)

0.94(0.18-3.98)

0.35(0.01-0.92)

0.47(0.09-1.86)

0.27(0.06-0.92)

GM 3 23 5,13,14 (22)

e3.81(1.18-11.78)

0.45(0.01-1.71)

0.76(0.12-1.32)

0.15(0.01-2.30)

aOther GM (80)

f0.58(0.11-2.09)

0.39(0.13-1.66)

0.59(0.18-1.09)

0.32(0.03-0.87)

KM 1 (11)

0.71(0.03-1.10)

0.13(0.01-0.44)

0.28(0.10-0.82)

0.47(0.38-0.95)

KM 1,3 (80)

0.67(0.27-1.96)

0.49(0.14-1.09)

0.57(0.23-1.06)

0.33(0.04-0.69)

KM 3 (119)

0.94 (0.19-3.69)

0.37(0.01-1.06)

0.57(0.21-1.14)

0.29(0.03-0.85)

  1. aOther GM [(GM 1,17 21 (n = 5), GM 1,17 5,6,14,21 (n = 5), GM 3 5,13,14 (n = 4), GM 1,17 13,21 (n = 5), GM 1,17 6,14,21 (n = 1), GM 1,2,17 13,21 (n = 5), GM 1,2,17 13,14,21 (n = 3), GM 1,3,17 13,14,21 (n = 2), GM 1,17 23 5,13,14,21 (n = 2), GM 1,17 5,6,13,14 (n = 5), GM 1,17 5,6,13,14,21 (n = 4), GM 1,17 5,14,21 (n = 2), GM 1,2,17 5,6,13,14,21 (n = 2), GM 1,2,17 5,6,14,21 (n = 4), GM 1,2,17 5,6,21 (n = 2), GM 1,2,3,17 5,6,13,14,21 (n = 1), GM 1,3,17 23 5,13,14 (n = 1), GM 1,3,17 23 5,6,13,14,21 (n = 5), GM 1,3,17 5,13,14 (n = 5), GM 1,3,17 5,6,13,14 (n = 5), GM 1,3,17 5,6,13,14,21 (n = 3), GM 1,2,17 5,13,14,21 (n = 4), GM 1,2,3,17 5,13,14,21 (n = 5)]
  2. bsignificantly lower (P = 0.019), csignificantly lower (P = 0.0003), dsignificantly higher (P = 0.007), esignificantly higher (P = 0.002), fsignificantly lower (P = 0.029) (obtained by Wilcoxon-Mann-Whitney test) compared with the rest of the GM phenotypes.